Lyra Therapeutics, Inc.盘中异动早盘快速拉升7.09%报0.121美元

市场透视2025-05-16

北京时间2025年05月16日21时48分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价快速拉升7.09%。截至发稿，该股报0.121美元/股，成交量112.053万股，换手率1.69%，振幅5.76%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-0.13美元，毛利55000.00美元，市盈率-0.10倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2535315069?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-16 21:48","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2535315069","market":"us","top_or_hot":-1,"title":"Lyra Therapeutics, Inc.盘中异动 早盘快速拉升7.09%报0.121美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月16日21时48分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价快速拉升7.09%。截至发稿，该股报0.121美元/股，成交量112.053万股，换手率1.69%，振幅5.76%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-0.13美元，毛利55000.00美元，市盈率-0.10倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621480694f9121b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lyra Therapeutics, Inc.盘中异动 早盘快速拉升7.09%报0.121美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLyra Therapeutics, Inc.盘中异动 早盘快速拉升7.09%报0.121美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-16 21:48 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621480694f9121b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月16日21时48分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价快速拉升7.09%。截至发稿，该股报0.121美元/股，成交量112.053万股，换手率1.69%，振幅5.76%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-0.13美元，毛利55000.00美元，市盈率-0.10倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621480694f9121b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LYRA","symbol_name":"Lyra Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621480694f9121b&s=b","article_id":"2535315069","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051621480694f9121b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2535315069","pubTimestamp":1747403285,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月16日21时48分，Lyra Therapeutics, Inc.股票出现异动，股价快速拉升7.09%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1877.64%、1554.72%、857.63%，振幅较大的相关个股有Affimed N.V.、Pasithea Therapeutics Corp.、Vor Biopharma Inc.，振幅分别为404.58%、32.54%、27.79%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于开发和商业化针对患者的局部治疗的创新的药物与递送一体化解决方案。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LYRA":"Lyra Therapeutics","BK4007":"制药","BK4539":"次新股","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Lyra Therapeutics, Inc. rose 7.09% to $0.121 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LYRA":1,"LENZ":1},"content_text":"北京时间2025年05月16日21时48分，Lyra Therapeutics, Inc.（LYRA.us）股票出现异动，股价快速拉升7.09%。截至发稿，该股报0.121美元/股，成交量112.053万股，换手率1.69%，振幅5.76%。最近的财报数据显示，该股实现营业收入183000.00美元，净利润-8.55百万美元，每股收益-0.13美元，毛利55000.00美元，市盈率-0.10倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Affimed N.V.、Inozyme Pharma, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 (To Pur Com)涨幅较大，Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1877.64%、1554.72%、857.63%，振幅较大的相关个股有Affimed N.V.、Pasithea Therapeutics Corp.、Vor Biopharma Inc.，振幅分别为404.58%、32.54%、27.79%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于开发和商业化针对患者的局部治疗的创新的药物与递送一体化解决方案。公司的运营和业务管理作为一个单一的运营部门，即开发针对耳、鼻、喉（ENT）疾病的靶向药物。其初步产品候选物 LYR-210 和 LYR-220 是生物可吸收聚合物基质，旨在通过简短、非侵入性、在诊所进行的操作给药，并计划持续向鼻窦通道递送药物，以治疗慢性鼻窦炎（CRS）。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2535315069","isCrawlerRequest":true}

Lyra Therapeutics, Inc.盘中异动 早盘快速拉升7.09%报0.121美元

精彩评论

Lyra Therapeutics, Inc.盘中异动早盘快速拉升7.09%报0.121美元